MIRADOR THERAPEUTICS
Summary
Mirador is a next-generation precision medicine company focused on immunology and inflammation.
Deals Overview
Total Deals1
Valued Deals1
Total Value£ 314 M
Avg. Deal Size£ 314 M
Senior Management
Mark McKenna
Chairman and CEO
Vika Brough
CFO
All rights reserved. Copyright © 2025 Datasite